SCHEME 1. Retrosynthesis for Goniothalesdiol
Stereoselective Synthesis of (+)-Goniothalesdiol
Kavirayani R. Prasad* and Shivajirao L. Gholap
Department of Organic Chemistry, Indian Institute of Science,
Bangalore 560012, India
ReceiVed January 24, 2006
Four syntheses of this bioactive tetrahydrofuran have been
reported, and a formal approach has also been disclosed. A
chiron approach starting from D-glucuronolactone5 and D-man-
nitol6 were disclosed by Yoda et al. and Babjak et. al. However,
both these methods employ either a lengthy reaction sequence
(16 steps from glucuronolactone for the unnatural goniothales-
diol) or a nonstereoselective process from mannitol, which
involves the separation of diastereomers. The elaboration of anti-
aldol adducts from erythrulose was the key step in the approach
for the formal synthesis of goniothalesdiol by Murga et al.7
Sharpless catalytic asymmetric epoxidation and Sharpless asym-
metric dihydroxylation reactions were utilized in the recent
synthesis reported by Yadav et. al., starting from cinnamyl
alcohol.8 More recently, Carreno et. al. have reported the syn-
thesis starting from tartaric acid ester, involving a sulfoxide
strategy pioneered by Solladie.9
Stereoselective synthesis of antitumor tetrahydrofuran
(+)-goniothalesdiol was achieved in high overall yield from
(-)-D-tartaric acid. Key features include an FeCl3 mediated
THF formation with very high selectivity. Synthesis of
natural gonithalesdiol and its analogue 2,5-bis-epi-goniotha-
lesdiol was achieved from a common intermediate.
Our approach to the synthesis of goniothalesdiol 1 was based
on an intramolecular stereospecific cyclization of the hydroxy
tosylate 5a of 1,4-diol 5 (Scheme 1). It was envisaged to syn-
thesize the required hydroxy tosylate 5a from the silyloxyketone
4, which can easily be obtained from tartaric acid. It was also
visualized that altering the sequence of intramolecular ether
formation, that is, the regioselective cyclization of the hydroxy
tosylate 5b would lead to the synthesis of goniothalesdiol
analogue 2.
The synthetic sequence was started with the silyloxyketone
4, which was readily obtained from the bisdimethylamide of
tartaric acid 3, employing a combination of selective Grignard
additions and a stereoselective reduction.10 Reduction of ketone
4 with L-selectride produced the alcohol 6 with very high
selectivity.11 Alcohol 6 was protected as its methoxy methyl
The tetrahydrofuran backbone is a ubiquitous heterocyclic
unit found in a number of biologically active natural products
such as Annonaceae acetogenins1 and polyether antibiotics.2
Goniothalesdiol (1), isolated from the bark of the Malaysian
tree Goniothalamus borneensis, is another type of tetrahydro-
furan having a 3,4-dihydroxy 2,5-dialkyl substitution.3 The
widespread antitumor activity commonly exhibited by the
styryllactones is also associated with this compound and is found
to show promising activity against P388 mouse leukemia cells.4
(5) (a) Yoda, H.; Nakaseko, Y.; Takabe, K. Synlett 2002, 1532. (b) For
a synthesis of 2-epi-goniothalesdiol, see: Yoda, H.; Simojo, T.; Takabe,
K. Synlett 1999, 1969.
(6) (a) Babjak, M.; Kapitan, P.; Gracza, T. Tetrahedron Lett. 2002, 43,
6983. (b) Babjak, M.; Kapitan, P.; Gracza, T. Tetrahedron 2005, 61, 2471.
(7) Murga, J.; Ruiz, P.; Falomir, E.; Carda, M.; Peris, G.; Marco, J.-A.
J. Org. Chem. 2004, 69, 1987.
(8) Yadav, J. S.; Raju, A. K.; Rao, P. P.; Rajaiah, G. Tetrahedron:
Asymmetry 2005, 16, 3283.
(9) Carreno, M. C.; Hernandez-Torres, G.; Urbano, A.; Colobert, F. Org.
Lett. 2005, 7, 5517.
(10) Prasad, K. R.; Gholap. S. L. Synlett 2005, 2260.
(11) The formation of other diastereomers was not observed within
detectable limits in the 1H NMR spectrum. Reduction with reducing agents
such as NaBH4 and DIBAL-H was not selective and produced diastereomeric
alcohols in varying ratios.
* Corresponding author. Fax: +918023600529.
(1) (a) Bermejo, A.; Figadere, B.; Zafra-Polo, M.-C.; Barrachina, I.;
Estornell, E.; Cortes, D. Nat. Prod. ReV. 2005, 22, 269. (b) Alali, F. Q.;
Liu, X.-X.; McLaughlin, J. L. J. Nat. Prod. 1999, 62, 504. (c) Cave, A.;
Figadere, B.; Laurens, A.; Cortes, D. Acetogenins from Annonaceae. In
Progress in the Chemistry of Organic Natural Products; Herz, W., Eds;
Springer-Verlag: New York, 1997; Vol. 70, pp 81-288.
(2) Faul, M. M.; Huff, B. E. Chem. ReV. 2000, 100, 2407.
(3) Cao, S.-G.; Wu, X.-H.; Sim, K.-Y.; Tan, B. K. H.; Pereira, J. T.;
Goh, S.-H. Tetrahedron 1998, 54, 2143.
(4) For a review on the cytotoxic activity and other bioactivity of
styryllactones: (a) Mereyala, H. B.; Joe, M. Curr. Med. Chem: Anti-Cancer
Agents 2001, 1, 293. (b) Bla`zquez, M. A.; Bermejo, A.; Zafra-Polo, M. C.;
Cortes, D. Phytochem. Anal. 1999, 10, 161.
10.1021/jo060159f CCC: $33.50 © 2006 American Chemical Society
Published on Web 03/30/2006
J. Org. Chem. 2006, 71, 3643-3645
3643